129 related articles for article (PubMed ID: 24499082)
1. Sevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in Japan.
Oka Y; Miyazaki M; Matsuda H; Takatsu S; Katsube R; Mori T; Takehara K; Umeda Y; Uno F
Ther Apher Dial; 2014 Feb; 18(1):37-43. PubMed ID: 24499082
[TBL] [Abstract][Full Text] [Related]
2. A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients.
Oka Y; Miyazaki M; Takatsu S; Oohara T; Toda K; Uno F; Matsuda H
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):283-6. PubMed ID: 19075639
[TBL] [Abstract][Full Text] [Related]
3. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
Oka Y; Miyazaki M; Takatsu S; Kunitomo K; Uno F; Maruyama M; Matsuda H
Ther Apher Dial; 2007 Apr; 11(2):107-13. PubMed ID: 17381531
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.
Ramos R; Moreso F; Borras M; Ponz E; Buades JM; Teixidó J; Morey A; Garcia C; Vera M; Doñate MT; de Arellano MR; Barbosa F; González MT
Perit Dial Int; 2007; 27(6):697-701. PubMed ID: 17984434
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
Pai AB; Shepler BM
Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
[TBL] [Abstract][Full Text] [Related]
6. Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients.
Sonikian M; Metaxaki P; Iliopoulos A; Marioli S; Vlassopoulos D
Ren Fail; 2006; 28(5):411-8. PubMed ID: 16825091
[TBL] [Abstract][Full Text] [Related]
7. Sevelamer worsens metabolic acidosis in hemodialysis patients.
De Santo NG; Frangiosa A; Anastasio P; Marino A; Correale G; Perna A; Di Stazio E; Stellato D; Santoro D; Di Meglio E; Iacono G; Ciacci C; Savica V; Cirillo M
J Nephrol; 2006; 19 Suppl 9():S108-14. PubMed ID: 16736432
[TBL] [Abstract][Full Text] [Related]
8. Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
Akatsuka T; Mochizuki T; Koike T
Ther Apher Dial; 2008 Jun; 12(3):216-25. PubMed ID: 18503699
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis—sevelamer hydrochloride, calcium carbonate, and bixalomer.
Sanai T; Tada H; Ono T; Fukumitsu T
Hemodial Int; 2015 Jan; 19(1):54-9. PubMed ID: 24980286
[TBL] [Abstract][Full Text] [Related]
10. Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.
Hatakeyama S; Murasawa H; Narita T; Oikawa M; Fujita N; Iwamura H; Mikami J; Kojima Y; Sato T; Fukushi K; Ishibashi Y; Hashimoto Y; Koie T; Saitoh H; Funyu T; Ohyama C
BMC Nephrol; 2013 Oct; 14():222. PubMed ID: 24119202
[TBL] [Abstract][Full Text] [Related]
11. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.
Fishbane S; Delmez J; Suki WN; Hariachar SK; Heaton J; Chasan-Taber S; Plone MA; Moe S
Am J Kidney Dis; 2010 Feb; 55(2):307-15. PubMed ID: 20042256
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
Pagé D; Knoll G
Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
Chen JB; Chiang SS; Chen HC; Obayashi S; Nagasawa M; Hexham JM; Balfour A; Junge G; Akiba T; Fukagawa M
Nephrology (Carlton); 2011 Nov; 16(8):743-50. PubMed ID: 21854503
[TBL] [Abstract][Full Text] [Related]
14. Chronic acid-base perturbations in hemodialysis patients treated with sevelamer hydrochloride: a two-year follow-up study.
Vlahakos DV; Retsa K; Kalogeropoulou S; Katsoudas S; Bacharaki D; Agroyannis B
Artif Organs; 2007 Dec; 31(12):892-5. PubMed ID: 17924988
[TBL] [Abstract][Full Text] [Related]
15. Sevelamer treatment strategy in peritoneal dialysis patients: conventional dose does not make best use of resources.
Chow KM; Szeto CC; Kwan BC; Leung CB; Li PK
J Nephrol; 2007; 20(6):674-82. PubMed ID: 18046669
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
Delmez J; Block G; Robertson J; Chasan-Taber S; Blair A; Dillon M; Bleyer AJ
Clin Nephrol; 2007 Dec; 68(6):386-91. PubMed ID: 18184521
[TBL] [Abstract][Full Text] [Related]
17. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.
Brezina B; Qunibi WY; Nolan CR
Kidney Int Suppl; 2004 Sep; (90):S39-45. PubMed ID: 15296506
[TBL] [Abstract][Full Text] [Related]
18. Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
Inoue T; Nagatoya K; Kagitani M; Shibahara N; Ueda H; Katsuoka Y; Ohashi S; Kitagawa Y; Nishimoto K; Yasuda H;
Ther Apher Dial; 2007 Jun; 11(3):210-4. PubMed ID: 17498003
[TBL] [Abstract][Full Text] [Related]
19. Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
Sonikian MA; Pani IT; Iliopoulos AN; Koutala KG; Marioli SI; Vlassopoulos DA
Ren Fail; 2005; 27(2):143-7. PubMed ID: 15807177
[TBL] [Abstract][Full Text] [Related]
20. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
